Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | TLR2 | O60603 | 1/20 | 0.30 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.30 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.30 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | GRM8 | O00222 | 1/20 | 0.30 |
| ▸ | GRM6 | O15303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13764588 | 1.00 | FFAR1 (0.35) | FFAR1LMNAALDH1A1POLBCA1 | |
| SCHEMBL30663831 | 0.87 | USP2 (0.31) | USP2TLR2 | |
| SCHEMBL4238297 | 0.76 | TRPA1 (0.33) | TRPM8USP2 | |
| SCHEMBL3978115 | 0.68 | LMNA (0.33) | LMNAALDH1A1POLBCA1CA2 | |
| SCHEMBL12985560 | 0.66 | — | — | |
| SCHEMBL12985951 | 0.66 | — | — | |
| SCHEMBL13089679 | 0.66 | — | — | |
| SCHEMBL12986445 | 0.66 | — | — | |
| SCHEMBL327613 | 0.66 | — | — | |
| SCHEMBL327612 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4532614-A1 | WATERBORNE ANTIFOULING COMPOSITION | Jotun A/S (NO) | 2025-04-09 | — | — | EP | disclosed |
| WO-2025051850-A1 | ANTIFOULING COATING SYSTEM | JOTUN A/S (NO) | 2025-03-13 | — | — | WO | disclosed |
| WO-2023232825-A1 | WATERBORNE ANTIFOULING COMPOSITION | JOTUN A/S (NO) | 2023-12-07 | — | — | WO | disclosed |
| EP-3710538-A1 | ANTIFOULING COMPOSITION | Jotun A/S (NO) | 2020-09-23 | — | — | EP | disclosed |
| WO-2019179917-A1 | COMPOSITION | JOTUN A/S (NO) | 2019-09-26 | — | — | WO | disclosed |
| WO-2018158437-A1 | COMPOSITION | JOTUN A/S (NO) | 2018-09-07 | — | — | WO | disclosed |
| EP-1695956-B1 | CYCLIC CARBOXYLIC ACID COMPOUND AND USE THEREOF | CHUGOKU MARINE PAINTS (JP) | 2012-06-20 | — | — | EP | disclosed |
| US-7557148-B2 | Cyclic carboxylic acid compound and use thereof | CHUGOKU MARINE PAINTS, LTD. (JP) | 2009-07-07 | — | — | US | disclosed |
| US-20070105976-A1 | Cyclic carboxylic acid compound and use thereof | CHUGOKU MARINE PLANTS, LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| EP-1695956-A1 | CYCLIC CARBOXYLIC ACID COMPOUND AND USE THEREOF | CHUGOKU MARINE PAINTS, LTD. (JP) | 2006-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105976-A1 | Cyclic carboxylic acid compound and use thereof | PORCN, PHOSPHO1, CA1 | FFAR1 241/4885LMNA 4390/4885ALDH1A1 1385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.